[1] WEISS SH, GOEDERT JJ, SARNGADHARAN MG, et al. Screen-ing test for HTLV-III (AIDS agent) antibodies:Specificity, sensi-tivity, and applications[J]. JAMA, 2014, 312 (4) :442.
|
[2] LI M, SHEN Y, JIANG X, et al. Clinical epidemiology of HIV/AIDS in China from 2004-2011[J]. Biosci Trends, 2014, 8 (1) :52-58.
|
[3] ZHENG Z, LI Y, JIANG Y, et al. Population HIV transmissionrisk for serodiscordant couples in Guangxi, Southern China:Acohort study[J]. Medicine (Baltimore) , 2018, 97 (36) :e12077.
|
[4] PANTAZIS N, CHINI M, ANTONIADOU A, et al. The HIV pa-tient profile in 2013 and 2003:Results from the Greek AMACScohort[J]. PLo S One, 2018, 13 (9) :e0203601.
|
[5] OHNISHI K, UCHIYAMA-NAKAMURA F. Metronidazole treat-ment for acute phase amoebic liver abscess in patients co-in-fected with HIV[J]. Int J STD AIDS, 2012, 23 (8) :e1-e3.
|
[6] HUANG Y, ZHANG WH. Research advances in diagnosis andtreatment of bacterial liver abscess[J]. J Clin Hepatol, 2018, 34 (3) :641-644. (in Chinese) 黄洋, 张伟辉.细菌性肝脓肿的诊治进展[J].临床肝胆病杂志, 2018, 34 (3) :641-644.
|
[7] YANG XP, ZHANG Y, WANG LS, et al. Evaluation on efficacyand safety of precise treatment guided by ultrasound for ac-quired immune deficiency syndrome patients with liver abscess[J/CD]. Chin J Exp Clin Infect Dis:Electronic Edition, 2017, 11 (3) :277-281. (in Chinese) 杨学平, 张瑶, 王连双, 等.超声引导精准治疗获得性免疫缺陷综合征合并肝脓肿的疗效及安全性评价[J/CD].中华实验和临床感染病杂志:电子版, 2017, 11 (3) :277-281.
|
[8] SERRAINO C, ELIA C, BRACCO C, et al. Characteristics andmanagement of pyogenic liver abscess:A European experi-ence[J]. Medicine (Baltimore) , 2018, 97 (19) :e0628.
|
[9] SAYANA S, RICAURTE JC, KHANLOU H. An unusual pathogenfor a liver abscess in a human immunodeficiency virus-infectedindividual[J]. Am J Med Sci, 2010, 339 (3) :290-291.
|